This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
LiveRamp (RAMP) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
LiveRamp (RAMP) delivered earnings and revenue surprises of 350% and 2.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
IQV vs. APP: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
IQV vs. APP: Which Stock Is the Better Value Option?
AppLovin (APP) Q1 Earnings Beat Estimates
by Zacks Equity Research
AppLovin (APP) delivered earnings and revenue surprises of 700% and 24.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The Trade Desk (TTD) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
The Trade Desk's (TTD) first-quarter 2022 results reflect gains from solid customer retention and a growing partner ecosystem.
Analysts Estimate AppLovin (APP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
AppLovin (APP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Refresh Your Portfolio by Dumping These 5 Toxic Stocks
by Rimmi Singhi
Get rid of toxic stocks like GoodRx (GDRX), Insulet (PODD), Vonage (VG), AppLovin (APP) and Embraer (ERJ) to avoid portfolio bleeding.
Twitter (TWTR) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Twitter's (TWTR) first-quarter 2022 performance is expected to reflect strong ad revenues and initiatives to add monetizing features to boost creator and user engagement.
New Strong Sell Stocks for April 19th
by Zacks Equity Research
ANIK, APP, and ARCE have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2022.
Reduce Investment Risk by Dumping These Toxic Stocks Now
by Rimmi Singhi
It's time to cut ties with toxic stocks like Marcus (MCS), TripAdvisor (TRIP), AppLovin (APP) and Cano Health (CANO) to protect your portfolio health amid severe volatility.
VNT vs. APP: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
VNT vs. APP: Which Stock Is the Better Value Option?
Twitter (TWTR) To Sell Mobile Ad Unit MoPub to AppLovin for $1B
by Zacks Equity Research
Twitter (TWTR) agrees to sell MoPub mobile advertising network to AppLovin to develop its owned and operated revenue products.
IPOs See Best Q2 in 2 Decades: ETFs to Ride the Boom
by Sweta Killa
The U.S. IPO market set another milestone in the second quarter with 113 IPOs raising $39.9 billion, marking the busiest quarter in over two decades.